RecruitingBladder CarcinomaGastric CarcinomaLiver and Intrahepatic Bile Duct Carcinoma
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Eligible age
21–100 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.
Sponsor: University of California, Davis
You may qualify if…
- ✓ Patient receiving treatment for the above 4 cancers (bladder cancer, lung cancer, gastric/stomach cancer, and liver cancer)
- ✓ Signed informed consent that will be put on file
You may not qualify if…
- ✕ No informed consent obtained
- ✕ Specimen unacceptable/degraded/etc.
- ✕ Individuals who are not yet adults (infants, children, teenagers)
- ✕ Pregnant women
- ✕ Prisoners
- ✕ Adults unable to consent
Where it's recruiting
California
Orange · Sacramento
Source: ClinicalTrials.gov · NCT04410302 · last updated 2026-08-20